Pardes Biosciences Inc (PRDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | ||||
| Current Assets | ||||
| Other current assets | 2,500 | 3,670 | 11,990 | 2,170 |
| TOTAL | $2,500 | $3,670 | $11,990 | $2,170 |
| Non-Current Assets | ||||
| PPE Net | 300 | 6,330 | 10,400 | 2,880 |
| Investments And Advances | 0 | 0 | 2,000 | 0 |
| Other Non-Current Assets | 2,600 | 37,560 | 115,680 | 4,150 |
| TOTAL | $2,900 | $43,890 | $128,080 | $7,030 |
| Total Assets | $5,400 | $47,560 | $140,070 | $9,200 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 620 | 5,450 | 3,060 | 2,320 |
| Accrued Expenses | 5,570 | 11,450 | 12,070 | 4,710 |
| Other current liabilities | 1,370 | 330 | 2,890 | 1,060 |
| TOTAL | $7,600 | $17,320 | $18,470 | $8,270 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 3 | 0 | 2 |
| TOTAL | $119 | $213 | $9,260 | $632 |
| Total Liabilities | $7,719 | $17,533 | $27,730 | $8,902 |
| Shareholders' Equity | ||||
| Common Shares | 30 | 30 | 30 | 20 |
| Other shareholders' equity | 180 | -110 | -570 | -290 |
| TOTAL | $230,770 | $229,320 | $227,210 | $108,130 |
| Total Liabilities And Equity | $238,489 | $246,853 | $254,940 | $117,032 |